Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Metabolic markers linked to pain and central sensitization in women with lipedema

Official title: THE IMPACT OF METABOLIC STATUS ON PAIN AND CENTRAL SENSITIZATION IN WOMEN WITH LIPEDEMA: A CROSS-SECTIONAL OBSERVATIONAL STUDY

Run by Marmara University · NCT07468097 · Data updated 2026-11-12

This study will test whether metabolic measures like insulin resistance (HOMA-IR), triglyceride/HDL ratio, and HbA1c are linked to central sensitization and pain in women with lipedema.

More Lipedema trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment59 (estimated)
SponsorMarmara University
Academic / other
Locations1 site (Istanbul, Pendik)
StatusRecruiting
StartedMarch 9, 2026
Main results expectedFebruary 1, 2027
Study endsMarch 1, 2027
Registry record updatedMarch 12, 2026
Trial IDNCT07468097 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older with a diagnosis of lipedema, chronic pain for at least three months, capacity to consent and complete assessments, and not taking antidiabetic or lipid-lowering medications are ideal candidates.

Probably not a fit

People who are pregnant or breastfeeding, have diagnosed diabetes, active thyroid or other significant endocrine disorders, active infection, malignancy, severe systemic disease, major neurological/psychiatric disorders, or who are on antidiabetic or lipid-lowering therapy are unlikely to be eligible or to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional observational study will enroll adult women with diagnosed lipedema and chronic pain to collect metabolic markers (HOMA-IR, TG/HDL, HbA1c, fasting glucose/insulin), anthropometric measures (waist/hip circumference, BMI), and standardized pain and central sensitization assessments. Pain characterization will include intensity, pain phenotype, functional status, and validated central sensitization questionnaires, with possible quantitative sensory testing. Participants with diabetes, active endocrine or severe systemic disease, significant neurological or psychiatric disorders, or on antidiabetic or lipid-lowering medications are excluded to reduce confounding. Data analysis will examine associations between metabolic dysfunction and measures of central pain processing and clinical pain outcomes.

Why it matters

Potential benefit: If links are found, the findings could point to metabolic targets or lifestyle strategies to help reduce pain or central sensitization in women with lipedema.

How similar studies have gone: Metabolic dysfunction has been linked to chronic pain in other conditions, but applying these observations to lipedema is relatively novel and supported by limited prior data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being female and aged 18 years or older
* Having chronic pain persisting for at least 3 months
* Having sufficient cognitive ability to understand and respond to the assessment scales used in the study
* Voluntarily agreeing to participate in the study and providing written informed consent

Exclusion Criteria:

* Presence of a history of malignancy, active infection, inflammatory rheumatic disease, or severe systemic disease
* History of known neurological disorders (e.g., stroke, multiple sclerosis, epilepsy)
* Diagnosis of severe psychiatric disorders (e.g., psychotic disorders, bipolar disorder)
* Pregnancy or breastfeeding
* Presence of cognitive impairment or communication difficulties that could affect the study results
* Diagnosed diabetes mellitus
* Active thyroid disease (uncontrolled hypothyroidism or hyperthyroidism)
* Cushing's syndrome or other significant endocrine disorders
* Use of antidiabetic medications
* Use of lipid-lowering therapy (e.g., statins, fibrates)
* Systemic glucocorticoid use within the past 3 months
* Use of medications that may significantly affect central pain mechanisms (e.g., high-dose opioids, antipsychotic drugs)
* History of major surgery or invasive treatment for pain within the past 3 months

Where it's running

  • Marmara University Faculty of Medicine Pendik Training and Research Hospital
    Istanbul, Pendik, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.